Skip to search formSkip to main contentSkip to account menu

xuezhikang

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Atherosclerosis is a multifactorial vascular disease characterized by formation of inflammatory lesions. Secretory phospholipase… 
2016
2016
Abstract Background: The aim of this study was to assess the preventive effect of xuezhikang (XZK) to replace atorvastatin on the… 
Review
2009
Review
2009
Objective To assess the effectiveness of xuezhikang for treating diabetic kidney disease.Methods We searched the Cochrane Central… 
2007
2007
OBJECTIVE To evaluate the effect of Xuezhikang (XZK) on cardiac function and serum C-reactive protein (CRP) in patients with… 
2006
2006
OBJECTIVE To investigate whether xuezhikang has additional beneficial effect on lipid peroxidation, myocardial fibrosis… 
2004
2004
OBJECTIVE To observe the intervention of Xuezhikang (XZK) on patients of acute coronary syndrome (ACS) with different levels of… 
2002
2002
Objective:To compare the effects of xuezhikang and domestic simvastatin on the blood lipid profile in patients with… 
1999
1999
OBJECTIVE To study the effects of Xuezhikang on lipid profile, thromboxane (TX) A(2), prostacyclin (PGI(2)) in patients with… 
1997
1997
Xuezhikang is a new blood-lipid-regulating medicine. The components of Xuezhikang include HMG-CoA reductase inhibitor (lovastatin…